Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure

Article Abstract:

The beta blocker metoprolol not only reduces the mortality rate in patients with congestive heart failure, it improves their symptoms and decreases the amount of time spent in the hospital. This was the conclusion of researchers who randomly assigned 3,991 patients in 14 countries with congestive heart failure to take extended release metoprolol or a placebo. The mortality rate was 31% lower in the patients taking metoprolol and they spent less time in the hospital and had a better quality of life.

Evaluation, Congestive heart failure, Metoprolol, Congestive heart failure agents

---

Rosuvastatin in older patients with systolic heart failure

Article Abstract:

The results of clinical trial conducted by comparing rosuvastatin with placebo in elderly patients with systolic, ischemic heart failure are reported. Rosuvastatin was not effective as a therapy for heart failure, but was found to play significant role in reducing levels of both low-density lipoprotein cholesterol and high-sensitivity C-reactive protein.

United States, Comparative analysis, Dosage and administration, Heart failure, Placebos, Clinical report, Rosuvastatin

---

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease

Article Abstract:

Simvastatin appears to be cost-effective treatment for patients with heart disease. Simvastatin lowers cholesterol levels. Researchers used data from a Scandinavian study to estimate the cost effectiveness of simvastatin treatment according to age, sex, and cholesterol value prior to treatment. Direct cost savings from the reduction in costs associated with heart attacks ranged from $3,800 per year of life to $27,400, although savings disappeared among the elderly when the indirect costs of lost productivity were factored in. Results do not apply to prevention of heart disease.

Health aspects, Economic aspects, Coronary heart disease, Hypercholesterolemia, Simvastatin

Similar abstracts:

• Abstracts: The effects of ibuprofen on the physiology and survival of patients with sepsis. Efficacy and safety of recombinant human activated protein C for severe sepsis
• Abstracts: Effect of coinfection with GB virus C on survival among patients with HIV infection. Infection with GB virus C and reduced mortality among HIV-infected patients
• Abstracts: Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease
• Abstracts: Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race
• Abstracts: Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Cyclopentenone prostaglandins -- new allies in the war on inflammation

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.